Aigen Investment Management LP acquired a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,215 shares of the health services provider's stock, valued at approximately $539,000.
Other institutional investors have also added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after acquiring an additional 158 shares during the last quarter. Eastern Bank bought a new stake in shares of Maximus in the 4th quarter valued at $29,000. V Square Quantitative Management LLC boosted its stake in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd bought a new stake in shares of Maximus in the 4th quarter valued at $54,000. Finally, IFP Advisors Inc lifted its position in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research firms recently issued reports on MMS. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.
Check Out Our Latest Stock Analysis on Maximus
Insider Transactions at Maximus
In other Maximus news, CEO Bruce Caswell acquired 3,500 shares of the stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the purchase, the chief executive officer now directly owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. Insiders have acquired 7,008 shares of company stock valued at $497,835 in the last three months. 1.60% of the stock is currently owned by company insiders.
Maximus Price Performance
NYSE:MMS traded up $3.25 during mid-day trading on Friday, hitting $71.26. 871,938 shares of the stock traded hands, compared to its average volume of 477,070. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The company has a market cap of $4.03 billion, a PE ratio of 15.33 and a beta of 0.71. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The business's 50-day moving average price is $72.77 and its 200 day moving average price is $80.22.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date of this dividend was Friday, February 14th. Maximus's dividend payout ratio is presently 25.81%.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.